Patent details

Basic Information

Publication number:

EP1827483

PCT Application Number:

PCT/US/2005/045169

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP058539727

PCT Publication Number:

WO/2006/065861

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THERAPEUTIC FORMULATIONS OF KERATINOCYTE GROWTH FACTOR

French Title of Invention:

FORMULATIONS THERAPEUTIQUES DU FACTEUR DE CROISSANCE DES KERATINOCYTES

German Title of Invention:

THERAPEUTISCHE FORMULIERUNGEN VON KERATINOZYTEN-WACHSTUMSFAKTOR

SPC Number:

Dates

Filing date:

12/12/2005

Grant date:

02/07/2014

EP Publication Date:

02/07/2014

PCT Publication Date:

22/06/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/09/2007

EP B1 Publication Date:

02/07/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/12/2015

Expiration date:

12/12/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/12/2005

 

 

Name:

Swedish Orphan Biovitrum AB (publ)

Address:

-, 112 76 Stockholm, Sweden (SE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

28/08/2014

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

ROY Suzanne, E.

Address:

United States (US)

2

Name:

DHARMAVARAM Vasumathi

Address:

United States (US)

3

Name:

PURTELL Judith

Address:

United States (US)

4

Name:

TREUHEIT Michael, J.

Address:

United States (US)

Priority

Priority Number:

636210 P

Priority Date:

15/12/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/18;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages